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Available online 20 December 2008Insomnia is a potential cause of anxiety, depression, and anomalies of experience; separate
research has shown that anxiety, depression and anomalies of experience are predictors of
paranoia. Thus insomnia may contribute to the formation and maintenance of persecutory
ideation. The aim was to examine for the ﬁrst time the association of insomnia symptoms and
paranoia in the general population and the extent of insomnia in individuals with persecutory
delusions attending psychiatric services. Assessments of insomnia, persecutory ideation,
anxiety, and depressionwere completed by 300 individuals from the general population and 30
individuals with persecutory delusions and a diagnosis of non-affective psychosis. Insomnia
symptoms were clearly associated with higher levels of persecutory ideation. Consistent with
the theoretical understanding of paranoia, the associationwas partly explained by the presence
of anxiety and depression. Moderate or severe insomnia was present in more than 50% of the
delusions group. The study provides the ﬁrst direct evidence that insomnia is common in
individuals with high levels of paranoia. It is plausible that sleep difﬁculties contribute to the
development of persecutory ideation. The intriguing implication is that insomnia interventions
for this group could have the added beneﬁt of lessening paranoia.
© 2008 Elsevier B.V. Open access under CC BY license. Keywords:
Delusions
Persecutory
Paranoia
Insomnia
Psychosis1. Introduction
Clinical experience indicates that many individuals with
persecutory delusions have difﬁculties initiating and main-
taining sleep. The extent of the problem has never been
reported. Often the insomnia is simply a result of insufﬁcient
activity during the day and early retirement to bed. However
the relationship between insomnia and paranoia may hold
greater clinical and theoretical interest. The stressful experi-
ence of insomnia may lead to the lowering of mood and
anomalies of experience that drive persecutory ideation. The
intriguing clinical implication is that simple well-established
interventions for sleep difﬁculties could lessen paranoid
experience.
There is evidence consistent with the idea that sleep
disturbance has a role in the development of paranoia.
Insomnia is a risk factor for the development of emotionalO Box 077, Institute o
don SE5 8AF, United
an).
Y license. fdisorder (Ford and Kamerow,1989; Breslau et al.,1996;Morphy
et al., 2007) and an associationwith daytimemood disturbance
has been repeatedly demonstrated (Riedel and Lichstein, 2000;
Buysse et al., 2007). In separate research, paranoia has been
strongly linked with negative affect (Freeman et al., 2008b;
Bentall et al., in press), even being considered a type of anxious
fear (Freeman and Freeman, 2008). Therefore insomniamay be
one cause of the negative mood that leads to paranoia.
Anomalies of experience such as perceptual distortions and
hallucinations are also considered a key cause of paranoia
(Maher, 1988; Freeman et al., 2008a); therefore it is germane
that sleep deprivation has long been noted to produce
temporary psychotic-like experiences (Luby et al., 1960; West
et al., 1962). Sleep difﬁculties are a common prodromal feature
of schizophrenia (Birchwood et al., 1989; Yung and McGorry,
1996) and even in unmedicated patients with schizophrenia
there is evidence of increased sleep latency and decreased total
sleep time (Chouinard et al., 2004). At a neurobiological level it
has been suggested that the overactivity of dopamine D2
receptors in the striatum thought to underlie the positive
symptoms of schizophrenia also enhances wakefulness (Monti
and Monti, 2005).
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much more common in the general population than pre-
viously thought (Freeman et al., 2008b). A high prevalence of
insomnia has been recognised for longer. Approximately 30%
of the general population experience symptoms of insomnia,
with a third of this group having chronic insomnia (Ohayon,
2002;Walsh, 2004; Morin et al., 2006). This sleep disturbance
is associated with anxiety and depression (Taylor et al., 2005;
Breslau et al., 1996; Buckner et al., 2008); indeed, difﬁculties
falling or staying asleep are a symptom of the diagnoses of
depression, generalised anxiety disorder, and post-traumatic
stress disorder (APA, 2000). In the current study the aim was
to determine whether persecutory ideation and insomnia are
associated. A community samplewas used to obtain a range in
paranoia severity and avoid the complicating issues of
neuroleptic medication and high levels of inactivity. At the
same time the occurrence of insomnia in a group of patients
with persecutory delusions attending psychiatric services for
psychosis was also examined.
2. Method
2.1. Participants
The community sample comprised 300 individuals. There
were three entry criteria: aged 18 or above; able to read and
write in English; and no history of treatment for severe mental
illness (e.g. schizophrenia, bipolar disorder). The sample was
recruited via the distribution to local postcodes of leaﬂets
advertising research studies at King's College London. Those
who responded to the leaﬂet were screened for the entry
criteria over the telephone. Questionnaires were then com-
pleted at King's College London, by postal return or an Internet
website (only available to screened individuals). The clinical
group was recruited from adult services in the South London
and Maudsley NHS Foundation Trust. The entry criteria were
the presence of a current persecutory delusion, which met the
criteria of Freeman and Garety (2000), and a clinical diagnosis of
schizophrenia, schizo-affective disorder, or delusional disorder
(i.e. nonaffective psychosis).
2.2. Measures
2.2.1. Insomnia Severity Index (ISI) (Bastien et al., 2001)
The ISI is a seven-item self-report questionnaire based upon
the insomnia criteria of the Diagnostic and Statistical Manual of
MentalDisorders (APA,1994). The scale assesses sleep-onset and
sleep maintenance difﬁculties, associated distress, and inter-
ferencewith daily functioning. Each item is rated on a 0–4 scale.
The time period is the past fortnight. Higher scores indicate the
presence of symptoms of insomnia. The scalewas evaluated in a
sample of over two hundred individuals attending a sleep
disorders clinic, and has been repeatedly used in insomnia
studies (Buckner et al., 2008; Savard et al., 2005; Bernert et al.,
2007). The questionnaire shows convergent validity with daily
sleep diaries, signiﬁcant other reports and clinician ratings. In
the current study the scale showed high internal reliability
(Cronbach's Alpha=.89). The guidelines for the interpretation of
scores are: no clinically signiﬁcant insomnia (0–7), subthreshold
insomnia (8–14), clinical insomnia of moderate severity (15–21)
and severe clinical insomnia (22–28).2.2.2. Sleep-50 Questionnaire (Spoormaker et al., 2005)
The nine-item insomnia subscale of the Sleep-50 Ques-
tionnaire assesses difﬁculties falling and staying asleep over the
past month, but not interference with daily functioning. Each
item is rated on a scale of 1 to 4. Higher scores indicate the
presence of symptoms of insomnia. The scale was psychome-
trically evaluated in a sample of 400 students and 250 sleep
clinic patients. In the current study the internal reliability of the
scale was high (Cronbach's Alpha=.88). Clinical insomnia is
indicated by a score of 19 or above.
2.2.3. Green et al. Paranoid Thoughts Scale— Part B (Green et al.,
2008)
The G-PTS Part B is a self-report measure of the occurrence
of persecutory ideation in the past month. Each of the sixteen
items (e.g. ‘I was convinced there was a conspiracy against me’,
‘Certain individuals have had it in forme’, ‘I have deﬁnitely been
persecuted’) is rated on a scale from 1 to 5, and conforms to a
clear deﬁnition of persecutory ideation (Freeman and Garety,
2000). The total score can range from 16 to 80. Higher scores
indicate greater levels of persecutory thinking. The question-
naire has been psychometrically evaluated for use in both
clinical and non-clinical populations. The internal consistency
of the scale and test–retest reliability are good. Convergent
validity with the Paranoia Scale (Fenigstein and Vanable, 1992)
has been shown. In the current study the scale had very high
internal reliability (Cronbach's Alpha=.94).
2.2.4. Depression Anxiety Stress Scales (Lovibond and Lovibond,
1995)
The DASS is a 42-item instrument with three subscales
measuring symptomsofdepression, anxiety, and stressover the
past week. Each of the subscales consists of 14 itemswith a 0–3
scale (0=did not apply tomeat all, 3=applied tomeverymuch).
Higher scores indicate higher levels of emotional distress. The
scale has been shown to be reliable and valid in large clinical
and non-clinical populations (Brown et al., 1997; Crawford and
Henry, 2003; Page et al., 2007). The anxietyanddepression sub-
scales were used; each showed very high internal reliability in
the current study (Anxiety Cronbach's Alpha=.91, Depression
Cronbach's Alpha=.96). There are no items on the scales that
assess sleep difﬁculties.
2.3. Analysis
Analyseswere carried out using Stata Version 10.0 (StataCorp,
2008). Visual inspection showed that the measures of persecu-
tory ideation, anxiety and depression in the community sample
all showed considerable positive skew; 46.7%, 34.3% and 31.0%
had the minimum scores on the measures of paranoia, depres-
sion and anxiety respectively. These variables were therefore
recoded into ordinal categories: Paranoia (16, 17–20, 21–24, 25–
28, 29+), Depression (0,1–3, 4–6, 7–9,10–12,13+), Anxiety (0,1–3,
4–6, 7–9, 10+). The main analyses were ordinal logistic regres-
sions (using the Stata ologit command) with paranoia as the
dependent variable. In the ﬁrst stage insomnia was the
independent variable (controlling for age, sex, and working
status). In thesecondstagedepressionwasaddedasanadditional
independent variable. In the ﬁnal stage anxietywas added to the
model. This procedure was carried out separately for each of the
insomnia scales. There were no missing data. The models were
Table 2
Ordinal logistic regressions for the community sample (N=300) with paranoia
as the dependent variable and controlling for age, sex and work status
Odds ratio p-value 95% CI
1. Insomnia Severity Index 1.16 b .001 1.11, 1.22
2. Insomnia Severity Index 1.09 b .001 1.04, 1.15
Depression 1.73 b .001 1.46, 2.03
3. Insomnia Severity Index 1.04 .180 .98, 1.09
Depression 1.33 .002 1.11, 1.60
Anxiety 2.22 b .001 1.67, 2.96
1. Sleep-50 Insomnia 1.20 b .001 1.14, 1.26
2. Sleep-50 Insomnia 1.13 b .001 1.07, 1.19
Depression 1.67 b .001 1.41, 1.97
3. Sleep-50 Insomnia 1.07 .024 1.01, 1.13
Depression 1.31 .004 1.09, 1.58
Anxiety 2.12 b .001 1.59, 2.82
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had missing data for three cases, but the results were unaltered.
95% Conﬁdence Intervals (CI) are reported.
3. Results
3.1. Community group
The community group comprised 140men and 160women.
The mean age was 37.7 (SD=12.5). The reported ethnicities
were: White (n=216), Black-Caribbean (n=16), Black African
(n=18), Black-Other (n=6), Indian (n=6), Pakistani (n=1), and
other (n=35). One hundred and six participants were working
full-time, seventy were working part-time, thirteen were
retired, sixty-four were unemployed and forty-seven were
students. The educational qualiﬁcations were: none (n=19),
GCSE (n=57), AS/A-level (n=41), diploma (n=32), degree
(n=97), postgraduate degree (n=53).
Scores on the measures are shown in Table 1. Based on the
Insomnia Severity Index, 216 (72%) participants had no
clinically signiﬁcant insomnia, 62 (20.7%) participants had
sub-threshold insomnia, 17 (5.7%) participants had clinical
insomnia of moderate severity and 5 (1.7%) participants had
severe clinical insomnia. Therefore 28% of the community
sample had some degree of sleep difﬁculty. There was a high
correlation between ISI and Sleep-50 Insomnia scores, r= .83,
pb .001. Forty-six individuals (15.3%) scored above the cut-off
on the Sleep-50, indicating potential clinical insomnia.
Ordinal logistic regressions examining the association of
paranoia and insomnia are reported in Table 2. There is a
strong association of the insomnia scales with paranoia. For
the interpretation of the results it should be remembered that
the odds ratios for the insomnia scales refer to one-point
changes. A ten-point increase in the Insomnia Severity Index
is associated with an odds ratio of 4.4 for an increase in
paranoia category (1.16 raised to the power of 10). A ten-point
increase on the Sleep-50 scale is associated with an odds ratio
of 6.2 for an increase along the paranoia ordinal scale. 70% of
those in the highest category of paranoia scores had at least
sub-threshold insomnia difﬁculties as assessed by the ISI,
whereas this was the case for only 17% of the participants
without any paranoid ideation. On the Sleep-50 question-
naire, 59% in the highest paranoia category scored above the
cut-off for insomnia, whereas only 8% in the lowest paranoia
category scored similarly. It can be seen that when depression
is added to the regression models that the relationship of
insomnia to paranoia is lessened but that there is a uniqueTable 1
Questionnaire scores
Community group
(N=300)
Persecutory delusions
group (N=30)
Mean SD Min.–
Max.
Mean SD Min.–
Max.
Insomnia Severity Index 5.90 5.17 0–28 15.07 7.34 0–27
Sleep-50 Insomnia 13.89 4.95 9–35 23.07 8.44 11–36
GPTS-Part B
(persecutory ideation)
19.94 7.85 16–73 65.27 13.49 39–80
DASS — Depression 4.42 6.99 0–42 26.63 11.17 2–41
DASS — Anxiety 3.32 5.56 0–38 21.93 10.90 4–41contribution of each variable to predicting paranoia scores.
When anxiety is added then the relationship of insomnia to
paranoia is lessened substantially further, becoming statisti-
cally non-signiﬁcant for the ISI.
3.2. Clinical group
The persecutory delusions group comprised 18 men and 12
women. The mean age was 44.2 (SD=11.7). The reported
ethnicities were: White (n=16), Black-Caribbean (n=3), Black
African (n=5), Black-Other (n=3), Indian (n=1), and other
(n=2). Twenty-two patients were unemployed, three were
working part-time, three were retired, and one was a student.
The educational qualiﬁcations were: none (n=6), GCSE (n=10),
AS/A-level (n=5), diploma (n=6), degree (n=1), postgraduate
degree (n=2). The diagnoses were: schizophrenia (n=24),
schizo-affective disorder (n=4) and delusional disorder (n=2).
Antipsychotic medication data were converted into chlorpro-
mazine equivalents grouped into low (0–200 mg), medium
(200–400 mg) and high (≥400 mg); one personwas not taking
any medication, elevenwere on a low dose, fourteenwere on a
medium dose and four were on a high dose. Seven patients
were taking clozapine, seventeen patients were taking other
atypical antipsychotics, and ﬁve people were on typical
antipsychotic medication. Five patients were being prescribed
two different antipsychotic drugs.
The prevalence of insomnia in the persecutory delusions
group as assessed by the ISI was: 27% (n=8) severe clinical
insomnia, 27% (n=8) clinical insomniaofmoderate severity, and
30% (n=9) subthreshold insomnia. Only 17% (n=5) had no
clinically signiﬁcant insomnia. There was a high correlation
between ISI and Sleep-50 scores, r=.78, pb .001. Sixty percent
(n=18) of the persecutory delusions group scored above
the Sleep-50 insomnia cut-off. Scores did not differ by
medication level on the ISI, F(2, 26)=.137, p=.872, or the
Sleep-50, F(2,26)=.350, p=.708.
4. Discussion
The rates of sleep difﬁculties in the community samplewere
consistent with the epidemiological literature; almost 30% had
symptoms of insomnia and approximately 10% were in the
clinical range. But the unique focus of the study was on a
potential association between sleep difﬁculties and paranoid
283D. Freeman et al. / Schizophrenia Research 108 (2009) 280–284thinking. The resultswere clear: higher levels of insomniawere
associated with higher levels of persecutory thinking. Con-
ﬁrmation was provided by the high prevalence of insomnia in
the individualswith clinical paranoia. Insomnia ismost likely an
overlooked problem in psychiatric services for individuals with
persecutory delusions.
Sleep disturbance is already incorporated into a theore-
tical account of persecutory delusions (Freeman et al., 2006),
but its role had not been directly tested. In this study the
relationship between sleep and paranoia was largely ac-
counted for by levels of anxiety and depression. This is
unsurprising; both paranoia and sleep difﬁculties are closely
linked with negative affect. Nevertheless the mediating
routes between insomnia and paranoia require closer (and
more rigorous) examination. A second plausible route is via
the occurrence of perceptual anomalies. A lack of sleep may
cause a puzzling internal state for the individual that, in the
context of anxiety, is incorrectly attributed to external
threat. Study of the mechanisms underlying insomnia in
patients with persecutory delusions is also needed; sleep
disturbance may be partly maintained by established insom-
nia-related processes such as rumination, attention to sleep-
related threat, and dysfunctional beliefs about sleep (Harvey
et al., 2005).
The representativeness of the samples in the current study
is questionable; the community group was only a minority of
the many people leaﬂeted in the local postcodes, while the
clinical group was of a small size. There was also a reliance on
self-report assessments. The study focussed on a speciﬁc
experience (paranoid ideation), but it could be argued that
completion of a full diagnostic screening interview by the
non-clinical population would have provided information of
interest. However the key limitation of the study is the cross-
sectional design. The causal direction of the relationship
between insomnia and paranoia is unknown. It is plausible
that the insomnia assessed is simply a consequence of living
with paranoid fears, although a circular relationship between
insomnia, anxiety and paranoia is more probable. Long-
itudinal studies of the relationships are clearly warranted. A
priority is the evaluation of well-established insomnia
interventions (e.g. Espie, 2006; Harvey et al., 2007) for
individuals with delusions. These interventions will provide
a stronger test of the causal relationship between insomnia
and paranoia and hold the promise of enhancing the efﬁcacy
of treatments for delusional beliefs.
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